More than 7 out of 10 South Korean biotech companies are facing financial difficulties, and nearly 4 in 10 have considered ...

Researchers examined the heritability of body mass index (BMI), highlighting that genetics and the gut microbiome both play major roles in obesity risk. The review emphasizes that maternal microbiome ...

Honda Motor Co. Chief Executive Toshihiro Mibe called the decisions “a switch in the planned course,” while stressing the ...

Director of the Museum of Natural History and Foundation Professor in the Department of Biology Elizabeth Leger was named the ...

RIT biomedical engineering professor Cristian Linte and his research team are integrating artificial intelligence techniques ...

Fierce 15 nominations are open! We're searching for the most innovative, resourceful and visionary biotechs leading the way ...

All-Star status - four companies in Mainland China and two companies in the Rest of Asia achieve first place in six categories in their sectors.

David Garner, Evan Poncelet, Warren Marcus, Kia Davis, Jesse Posey, and Louis Newkirk. Marcus, CEO of Wink Therapeutics, won first place at a ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't ...

Regulatory bodies are promoting digital adoption by providing clearer guidance on software validation and post-market monitoring, helping to mitigate risks associated with eCOA implementations.